6550--INTENT TO SOLE SOURCE - Buffalo VA Thermo Fisher GENEXUS Reagents
| Location: |
Federal |
| Posted: |
Aug 20, 2026 |
| Due: |
Aug 27, 2026 |
| Agency: |
VETERANS AFFAIRS, DEPARTMENT OF |
| Type of Government: |
Federal |
| Category: |
- 65 - Medical, Dental, and Veterinary Equipment and Supplies
|
| Solicitation No: |
36C24226Q0938 |
| Publication URL: |
To access bid details, please log in. |
6550--INTENT TO SOLE SOURCE - Buffalo VA Thermo Fisher GENEXUS Reagents
Active
Contract Opportunity
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
242-NETWORK CONTRACT OFFICE 02 (36C242)
General Information
-
Contract Opportunity Type: Special Notice (Original)
-
Original Published Date: Aug 20, 2026 05:03 pm EDT
-
Original Response Date: Aug 27, 2026 10:00 am EDT
-
Inactive Policy: Manual
-
Original Inactive Date:
Sep 06, 2026
-
Initiative:
Classification
-
Original Set Aside:
-
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
-
325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
Description
This is a notice of intent to award a sole source contract and is not a request for quotes.
The Department of Veterans Affairs on behalf of the Buffalo VA Medical Center intends to award a Firm Fixed Price (FFP), sole source action to Large Businesses (LB).
Name of Contractor:
Thermo Fisher Scientific
Street Address:
5781 Van Allen Way
City, State, Zip:
Carlsbad, CA 92008 USA
The Pathology and Laboratory Medicine Department requires reagents and supplies outlined in this procurement to continue to perform patient testing on the Thermo Fisher Genexus instrument, and Genexus Purification System. Both instruments are owned and operated by the Buffalo VAMC Pathology and Laboratory Medicine department. The Genexus instrument utilizes the Oncomine Precision Assay which enables simultaneous detection of biomarkers across 50 genes, including key targets within EGFR, BRAF, KRAS, ALK, ROS1, NTRK, RET, HER2, and others, from solid tissue samples. Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The OPA NGS panel has significant clinical utility in cancer treatment by providing comprehensive genomic profiling of a tumor sample, allowing healthcare providers to identify actionable genetic alterations and select the most appropriate targeted therapies for a patient based on their specific tumor mutations, leading to more effective treatment plans.
Item number
Description
Quantity
A40261
Ion Torrent Genexus Barcodes 1-32- AS HD
12
A40266
Ion Torrent Genexus Pipette tips
7
4483354
96-well plates (20/box)
4
A40269
Ion Torrent GX5 Chip and Genexus Coupler
6
A40271
Genexus Sequencing Kit
6
AB0626
Adhesive Foil Seals Microp Lates oe PCR Plates
1
A40263
Genexus Templating Strips 3 and 4-GX5 (8/BOX)
7
A45539
Genexus FFPE DNA/RNA Purification Kit
6
A46291
Oncomine Precision Assay GX
12
This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a).
The Department of Veterans Affairs, Buffalo, NY location intends to issue a sole source award contract to Thermo Fisher Scientific, all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored.
NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing
Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels.
This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on August 27, 2025. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Gove
Attachments/Links
Contact Information
Contracting Office Address
-
113 HOLLAND AVE
-
ALBANY , NY 12208
-
USA
Secondary Point of Contact
History
-
Aug 20, 2026 05:03 pm EDTSpecial Notice (Original)
Daily notification on new contract opportunities
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
ONE WEEK FREE TRIAL
See also
...Follow PANEL FUEL MANAGEME Active Contract Opportunity Notice ID N0038326QA122 Related Notice... WEAPON ...
DEPT OF DEFENSE
Bid Due: 9/11/2026
...Follow PANEL,CONTROL,ELECT Active Contract Opportunity Notice ID N0038326QA124 Related Notice... WEAPON SYSTEMS SUPPORT ...
DEPT OF DEFENSE
Bid Due: 9/11/2026
...Follow PANEL, CONTROL, ELEC Active Contract Opportunity Notice ID N0038326QA123 Related Notice... NAVSUP ...
DEPT OF DEFENSE
Bid Due: 9/11/2026
...Follow FIRE ALARM / SECURITY PANEL REPLACEMENTS Active Contract Opportunity Notice ID... EQUIPMENT- ...
INTERIOR, DEPARTMENT OF THE
Bid Due: 9/10/2026
* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.